Alnylam Pharmaceuticals Leads Healthcare Sector in Q3 Earnings Surprises

As the third-quarter earnings season concludes, several healthcare companies have reported earnings-per-share (EPS) results that significantly outperformed Wall Street consensus estimates. This trend indicates localized strength across diverse sub-sectors, including biotechnology, pharmaceuticals, diagnostics, and managed care. Alnylam Pharmaceuticals emerged as the top performer with a substantial $14.01 EPS surprise. Other notable outperformers include Edgewise Therapeutics and GRAIL, demonstrating that positive earnings momentum is present across both specialized biotech firms and broader healthcare service providers.

By https://seekingalpha.com/user/59758342/bio · Seeking Alpha ·

Alnylam Pharmaceuticals Leads Healthcare Sector in Q3 Earnings Surprises

Tickers: $ALNY $GRAL $LLY $REGN

Topics: biotechnology earnings per share healthcare earnings pharmaceuticals

Read the full article at Seeking Alpha

Part of the story Reliance leads materials stocks with biggest Q3 earnings surprise (3 articles)

More World news